This blog is intended for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis, or treatment
It is sometimes prescribed off-label for weight management, and its weight loss benefits have led to the development of semaglutide-based treatments specifically targeting obesity, such as Wegovy
10.1016/j.cmet.2006.08.001 131
2023 is set to break all records for MP funds, except for the share of expenditure, where 8% was also reached in the boom year of 2008, but not sustained
Cheraghi E, Soleimani Mehranjani M, Shariatzadeh SMA, Nasr Esfahani MH, Alani B